Effects of psychopharmacotherapy on phenotypic expression of cytochrome P450 2D6 in patients genotyped for CYP2D6 mutations

被引：0
|
作者：
Zelenkáv, O [1 ]
Hadsová, E
Cesková, E
Vojtísková, M
Hyksová, M
机构：
[1] Masaryk Univ, Fac Med, Dept Pharmacol, CS-60177 Brno, Czech Republic
[2] Masaryk Univ, Fac Med, Psychiat Clin, CS-60177 Brno, Czech Republic
[3] Masaryk Univ, Fac Med, Dept Biochem, CS-60177 Brno, Czech Republic
[4] JG Mendel Fac Childrens Hosp, Dept Med Genet, Brno, Czech Republic
来源：
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | 2000年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：303 / 305
页数：3
相关论文
共 50 条
  • [1] INHIBITION OF HUMAN CYTOCHROME P450 2D6 (CYP2D6) BY METHADONE
    WU, D
    OTTON, SV
    SPROULE, BA
    BUSTO, U
    INABA, T
    KALOW, W
    SELLERS, EM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (01) : 30 - 34
  • [2] GENETIC POLYMORPHISM IN CYTOCHROME P450 2D6 (CYP2D6): POPULATION DISTRIBUTION OF CYP2D6 ACTIVITY
    Neafsey, Patricia
    Ginsberg, Gary
    Hattis, Dale
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 334 - 361
  • [3] Functional Characterization of Cytochrome P450 2D6 (CYP2D6) Allelic Variant CYP2D6*10
    Dong, A. N.
    Ong, C. E.
    Pan, Y.
    Palanisamy, U. D.
    Ismail, R.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 49 - 49
  • [4] Cytochrome p450 2D6 (CYP2D6) inhibitory constituents of Catharanthus roseus
    Usia, T
    Watabe, T
    Kadota, S
    Tezuka, Y
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (06) : 1021 - 1024
  • [5] Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping
    Streetman, DS
    Ellis, RE
    Nafziger, AN
    Leeder, JS
    Gaedigk, A
    Gotschall, R
    Kearns, GL
    Bertino, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (05) : 535 - 541
  • [6] Cytochrome P450 2D6 (CYP2D6) activity in relation to the antitussive effect of dextromethorphan
    Abdul-Manap, R
    Wright, CE
    Rostami-Hodjegan, A
    Meller, S
    Lennard, MS
    Morice, AH
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (05) : 586 - 587
  • [7] A longitudinal study of cytochrome P450 2D6 (CYP2D6) activity during adolescence
    Leeder, J. Steven
    Gaedigk, Andrea
    Wright, Krista J.
    Staggs, Vincent S.
    Soden, Sarah E.
    Lin, Yvonne S.
    Pearce, Robin E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (10): : 2514 - 2527
  • [8] Cytochrome P450 2D6 and schizophrenia.: Is the frequent CYP2D6*2 allele protective?
    Meary, A.
    Loriot, M. A.
    Brousse, G.
    Szoke, A.
    Schurhoff, F.
    Lancon, C.
    Llorca, P. M.
    Broly, F.
    Beaune, P.
    Leboyer, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 56 - 56
  • [9] Epitope Mapping of Cytochrome P450 2D6 in Patients with Autoimmune Hepatitis and in the CYP2D6 Mouse Model
    Hintermann, Edith
    Holdener, Martin
    Bayer, Monika
    Manns, Michael
    Christen, Urs
    CLINICAL IMMUNOLOGY, 2009, 131 : S135 - S136
  • [10] Cytochrome P450 2D6
    Owen, Ryan P.
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (07): : 559 - 562
12345